147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
More posts

Methods and compositions for treating triple negative breast cancer

Inventors analyzed the prognostic value of tumor and stromal-derived SPARC in a large series that included 148 non-metastatic TNBC patients with a […]

Method for diagnosing colorectal cancer

The present invention relates to the diagnosing of colorectal cancer. The inventors have thus designed an efficient, rapid and cost-effective method […]

Early and non-invasive method for assessing a subject’s risk of

In the present invention inventors perform studies on extracellular vesicles isolated from urine samples to assess the biomarker potential of measures […]

Specific t cell subpopulation for diagnosis, prognosis, risk

The invention relates to a method comprising a step of determining the number, concentration and/or proportion of T lymphocytes with a CD4+ CD8ααlow […]

Methods for prognosis, stratification and monitoring of the severity

In the present invention inventors used measured cytokine levels in serum of patients with COVID-19, at the time of hospital admission. Thereafter, […]

Method for diagnosing pancreatic cancer

The present invention relates to the diagnostics of pancreatic cancer. The inventors engineered a novel biomarker discovery approach, tailored for […]

Method for pronosis and treating a patient suffering from cancer

Complement components form a plasma innate immune cascade but could also serve as multitasking proteins, as they have functions beyond this system. […]

Gdf3 as biomarker and biotarget in post-ischemic cardiac remodeling

Markers of an intense scarring process in the early phase post- myocardial infarction (MI) are still undetermined, and the identification of patients […]

Method for early prediction of neurodegenerative decline

The present invention relates to a method for predicting risks of neurodegenerative decline of a patient, especially of mild cognitive impairment […]

Methods for detecting the presence of pemphigus-specific

Pemphigus is a group of rare autoimmune diseases that causes blistering of the skin and mucous membranes, and includes pemphigus vulgaris (PV) and […]

More posts

You might also be interested in

Contact

Inserm Transfert

Research tool licensing team

researchtools@inserm-transfert.fr